skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury

Abstract

Stroke is a complex disease that may involve oxidative stress-related pathways in its pathogenesis. The nuclear factor erythroid-2-related factor 2/antioxidant response element (Nrf2/ARE) pathway plays an important role in inducing phase II detoxifying enzymes and antioxidant proteins and thus has been considered a potential target for neuroprotection in stroke. The aim of the present study was to determine whether eriodictyol-7-O-glucoside (E7G), a novel Nrf2 activator, can protect against cerebral ischemic injury and to understand the role of the Nrf2/ARE pathway in neuroprotection. In primary cultured astrocytes, E7G increased the nuclear localization of Nrf2 and induced the expression of the Nrf2/ARE-dependent genes. Exposure of astrocytes to E7G provided protection against oxygen and glucose deprivation (OGD)-induced oxidative insult. The protective effect of E7G was abolished by RNA interference-mediated knockdown of Nrf2 expression. In vivo administration of E7G in a rat model of focal cerebral ischemia significantly reduced the amount of brain damage and ameliorated neurological deficits. These data demonstrate that activation of Nrf2/ARE signaling by E7G is directly associated with its neuroprotection against oxidative stress-induced ischemic injury and suggest that targeting the Nrf2/ARE pathway may be a promising approach for therapeutic intervention in stroke. - Highlights: • E7G activates Nrf2 in astrocytes.more » • E7G stimulates expression of Nrf2-mediated cytoprotective proteins in astrocytes. • E7G protects astrocytes against OGD-induced cell death and apoptosis. • The neuroprotective effect of E7G involves the Nrf2/ARE pathway. • E7G protects rats against cerebral ischemic injury.« less

Authors:
 [1];  [2]; ; ;  [1];  [3];  [1];  [2]
  1. Department of Pharmacology, School of Medicine, Shandong University, Jinan 250012 (China)
  2. Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, Jinan 250012 (China)
  3. Health Science Center, Paul L. Foster School of Medicine, Texas Tech University, El Paso, TX, 79905 (United States)
Publication Date:
OSTI Identifier:
22285548
Resource Type:
Journal Article
Journal Name:
Toxicology and Applied Pharmacology
Additional Journal Information:
Journal Volume: 273; Journal Issue: 3; Other Information: Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0041-008X
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; ANTIOXIDANTS; APOPTOSIS; BRAIN; CEREBRAL ARTERIES; GLUCOSE; GLUTATHIONE; IN VIVO; INJURIES; ISCHEMIA; LIGASES; OXIDATION; OXYGEN; PATHOGENESIS; RATS; RNA

Citation Formats

Jing, Xu, Ren, Dongmei, Wei, Xinbing, Shi, Huanying, Zhang, Xiumei, Perez, Ruth G., Lou, Haiyan, and Lou, Hongxiang. Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury. United States: N. p., 2013. Web. doi:10.1016/J.TAAP.2013.10.018.
Jing, Xu, Ren, Dongmei, Wei, Xinbing, Shi, Huanying, Zhang, Xiumei, Perez, Ruth G., Lou, Haiyan, & Lou, Hongxiang. Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury. United States. https://doi.org/10.1016/J.TAAP.2013.10.018
Jing, Xu, Ren, Dongmei, Wei, Xinbing, Shi, Huanying, Zhang, Xiumei, Perez, Ruth G., Lou, Haiyan, and Lou, Hongxiang. Sun . "Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury". United States. https://doi.org/10.1016/J.TAAP.2013.10.018.
@article{osti_22285548,
title = {Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury},
author = {Jing, Xu and Ren, Dongmei and Wei, Xinbing and Shi, Huanying and Zhang, Xiumei and Perez, Ruth G. and Lou, Haiyan and Lou, Hongxiang},
abstractNote = {Stroke is a complex disease that may involve oxidative stress-related pathways in its pathogenesis. The nuclear factor erythroid-2-related factor 2/antioxidant response element (Nrf2/ARE) pathway plays an important role in inducing phase II detoxifying enzymes and antioxidant proteins and thus has been considered a potential target for neuroprotection in stroke. The aim of the present study was to determine whether eriodictyol-7-O-glucoside (E7G), a novel Nrf2 activator, can protect against cerebral ischemic injury and to understand the role of the Nrf2/ARE pathway in neuroprotection. In primary cultured astrocytes, E7G increased the nuclear localization of Nrf2 and induced the expression of the Nrf2/ARE-dependent genes. Exposure of astrocytes to E7G provided protection against oxygen and glucose deprivation (OGD)-induced oxidative insult. The protective effect of E7G was abolished by RNA interference-mediated knockdown of Nrf2 expression. In vivo administration of E7G in a rat model of focal cerebral ischemia significantly reduced the amount of brain damage and ameliorated neurological deficits. These data demonstrate that activation of Nrf2/ARE signaling by E7G is directly associated with its neuroprotection against oxidative stress-induced ischemic injury and suggest that targeting the Nrf2/ARE pathway may be a promising approach for therapeutic intervention in stroke. - Highlights: • E7G activates Nrf2 in astrocytes. • E7G stimulates expression of Nrf2-mediated cytoprotective proteins in astrocytes. • E7G protects astrocytes against OGD-induced cell death and apoptosis. • The neuroprotective effect of E7G involves the Nrf2/ARE pathway. • E7G protects rats against cerebral ischemic injury.},
doi = {10.1016/J.TAAP.2013.10.018},
url = {https://www.osti.gov/biblio/22285548}, journal = {Toxicology and Applied Pharmacology},
issn = {0041-008X},
number = 3,
volume = 273,
place = {United States},
year = {2013},
month = {12}
}